Unlock instant, AI-driven research and patent intelligence for your innovation.

Methods for treating coginitive impairment and improving cognition

a cognition and coginitive impairment technology, applied in the field of coginitive impairment and cognition improvement, can solve the problems of ineffective treatment for new acquired experience, various forms of disruption, loss or impairment, and the initial sensitivity of new acquired experience to various forms of disruption, loss or impairment, and achieve the effect of improving memory of treated patients

Inactive Publication Date: 2007-05-24
COGNITION PHARMA
View PDF33 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

"The present invention relates to methods of improving memory function and performance in humans with impairments in memory consolidation. The invention involves administering specific amphetamine compounds, such as l-amphetamine or l-methamphetamine, to humans to enhance long-term memory function and performance. The invention also includes methods of assessing the degree of impairment in memory consolidation and determining the improvement in memory function after administering the amphetamine compounds. The technical effect of the invention is to provide effective treatment for humans with memory consolidation impairments."

Problems solved by technology

A newly acquired experience initially is susceptible to various forms of disruption.
Indeed, loss or impairment of long-term memory is a significant feature of such diseases, and no effective therapy for that effect has emerged.
Clinical management strategies currently provide minimal, if any, improvement in memory and cognitive function.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods for treating coginitive impairment and improving cognition
  • Methods for treating coginitive impairment and improving cognition
  • Methods for treating coginitive impairment and improving cognition

Examples

Experimental program
Comparison scheme
Effect test

example 1

Dose Response Testing

Effects of (S)-(+)-Amphetamine on Inhibitory Avoidance

[0653] In this experiment, rats were injected with three different doses of (S)-(+) amphetamine thirty minutes prior to being trained on the IA task. As can be seen from FIG. 1, a dose of about 2 mg / kg of amphetamine improved retention of the task, while doses of about 0.25, about 0.50 and about 1.0 mg / kg had no effect. In order to verify this result, a second experiment was conducted. Rats were injected with about 2.0 mg / kg of amphetamine and trained on the IA task. As can be seen from FIG. 2, this dose of (S)-(+)-amphetamine significantly improved retention of the task. An unpaired t-test demonstrated that this enhancement was statistically significant (p<0.01).

Effects of (R)-(−)-Amphetamine (C105) on Inhibitory Avoidance

[0654] The first experiment to be conducted using C105 was a dose response experiment, in which different doses of C105 (about 0.4, about 0.5, about 0.75, 1.0 and about 2.0 mg / kg) wer...

example 2

Time Course of Effectiveness

[0657] In this experiment, the time of drug administration was varied in order to determine the optimal pre-training drug administration time. FIG. 3 shows that (S)-(+) amphetamine (2.0 mg / kg) is effective when administered to the rats between 0 and 2 hours prior to training.

example 3

Long Term Retention

[0658] This experiment was conducted in order to determine whether the enhanced retention observed in Experiment 2 was long-lasting. Rats received a second retention test one week after the first retention test. No additional training or drug was administered to the animals in the interim period. FIG. 4 illustrates that rats that had received (S)-(+)-amphetamine the previous week performed significantly better than rats that had received control injections of vehicle solution (F(4,47)=3.688, p<0.01).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
thicknessaaaaaaaaaa
w/waaaaaaaaaa
diameteraaaaaaaaaa
Login to View More

Abstract

Cognitive impairments are treated and cognition is improved with an amphetamine compound. In one embodiment, the method includes administering an I-amphetamine compound. In another embodiment, the method includes administering an l-methamphetamine compound.

Description

RELATED APPLICATIONS [0001] This application is a continuation-in-part of U.S. application Ser. No. 10 / 791,223, filed Mar. 2, 2004, which is a continuation-in-part of U.S. application Ser. No. 10 / 444,970, filed May 23, 2003, which is a continuation-in-part of U.S. application Ser. No. 10 / 139,606, filed May 2, 2002, which is a continuation-in-part of U.S. application Ser. No. 10 / 003,740 filed Oct. 31, 2001, which claims the benefit of U.S. Provisional Application No. 60 / 245,323, filed on Nov. 1, 2000, and claims priority to International Application PCT / US01 / 45793, filed Oct. 31, 2001, which designates the United States and was published in English. This application also claims the benefit of U.S. Provisional Application No. 60 / 473,168, filed May 23, 2003. The teachings of the above applications are incorporated herein by reference in their entirety.BACKGROUND OF THE INVENTION [0002] The term “memory” subsumes many different processes and requires the function of many different brain...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K31/137
CPCA61K31/137
Inventor EPSTEIN, MEL H.WIIG, KJESTEN A.CARPENTER, RANDALL L.ZAREVICS, PETERARNOLD, H. MOORE
Owner COGNITION PHARMA